Soleno Therapeutics, Inc. (SLNO)

52.67 -0.11 (-0.21%) USD  |  NASDAQ  |  Apr 20, 16:00
52.68 +0.01 (+0.02%) After-Hours: 20:00
More

Soleno Therapeutics Cash and Short Term Investments (Quarterly) : 305.47M for Dec. 31, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SLNO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 1.480B
Nektar Therapeutics 245.75M
Forian, Inc. 31.55M
Boston Scientific Corp. 2.045B
Integer Holdings Corp. 17.16M